​
​

Chinook Therapeutics Ownership | Who Owns Chinook Therapeutics?

OverviewForecastChart

Chinook Therapeutics Ownership Summary

Chinook Therapeutics is owned by 81.54% institutional investors, and 18.46% retail investors. IQ Merger Arbitrage ETF is the top mutual fund, with 0.61% of its assets in Chinook Therapeutics shares.

KDNY Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockChinook Therapeutics81.54%-18.46%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202319523.42%58,379,049-4.61%811.09%12458.97%42-12.50%
Mar 31, 20231582.60%61,199,0165.24%861.23%78-484.35%
Dec 31, 20221541.99%58,150,4132.31%841.19%78-21.21%4658.62%
Sep 30, 202215111.03%56,835,7847.49%831.15%99-1.00%2920.83%
Jun 30, 202213628.30%52,874,21219.69%851.49%10092.31%24-25.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
IQ Merger Arbitrage ETF435.56K0.61%-
iShares Biotechnology ETF320.96K0.45%-
iShares Russell 2000 ETF272.34K0.38%-
AB Event Driven S1 USD151.71K0.21%-
Russell 2000 Index Non-Lendable Fund E124.37K0.17%27.37K
BlackRock Russell 2500™ Index F107.98K0.15%18.22K
iShares Russell 2000 Growth ETF105.69K0.15%-
iShares MSCI USA Sm-Cp Min Vol Fctr ETF72.50K0.10%-
BlackRock Russell 2000® Index NL F69.12K0.10%12.68K
BlackRock Russell 3000® Index F37.35K0.05%4.32K

Recent Insider Transactions

DateNameRoleActivityValue
Aug 01, 2023King Andrew James Chief Scientific OfficerSell$45.59K
May 30, 2023Greenman William Mariner-Sell$26.91K
Apr 24, 2023DOBMEIER ERIC President, CEOSell$513.53K
Apr 24, 2023DOBMEIER ERIC President, CEOBuy$26.71K
Apr 17, 2023Jerel Davis-Sell$6.14M

Insider Transactions Trends

DateBuySell
2023 Q3-1
2023 Q2-6
2023 Q1-13
2022 Q4-6
2022 Q312

KDNY Ownership FAQ

Who Owns Chinook Therapeutics?

Chinook Therapeutics shareholders are primarily institutional investors at 81.54%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Chinook Therapeutics's industry, Biotech Stocks , is 44.97%, which Chinook Therapeutics exceeds.

Does Blackrock own Chinook Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Chinook Therapeutics.

Who is the top mutual fund holder of Chinook Therapeutics shares?

IQ Merger Arbitrage ETF is the top mutual fund holder of Chinook Therapeutics shares, with 0.61% of its total shares outstanding invested in 435.56K Chinook Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools